HIV and HCV Intervention In Drug Treatment Settings - 1
- Conditions
- Behavior Therapy
- Registration Number
- NCT00102349
- Lead Sponsor
- University of Colorado, Denver
- Brief Summary
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 706
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HIV/HCV injection risk behaviors
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Denver Health & Hosp Authority
🇺🇸Denver, Colorado, United States
Island Grove RTC
🇺🇸Greeley, Colorado, United States
SSTAR (Stanley St. Treatment & Resources, Inc)
🇺🇸Fall River, Massachusetts, United States
James Gilmore Jr. Treatment Center
🇺🇸Kalamazoo, Michigan, United States
Willamette Family Treatment Services
🇺🇸Eugene, Oregon, United States
SSTAR of Rhode Island - North Kingstown
🇺🇸North Kingstown, Rhode Island, United States
Recovery Center King Co.-Kent Detox
🇺🇸Kent, Washington, United States
Recovery Center King Co.-Seattle Detox
🇺🇸Seattle, Washington, United States
Denver Health & Hosp Authority🇺🇸Denver, Colorado, United States